160 related articles for article (PubMed ID: 29183639)
1. Systematic review and meta-analysis of prognostic role of splenic vessels infiltration in resectable pancreatic cancer.
Crippa S; Cirocchi R; Maisonneuve P; Partelli S; Pergolini I; Tamburrino D; Aleotti F; Reni M; Falconi M
Eur J Surg Oncol; 2018 Jan; 44(1):24-30. PubMed ID: 29183639
[TBL] [Abstract][Full Text] [Related]
2. Splenic artery invasion in pancreatic adenocarcinoma of the body and tail: a novel prognostic parameter for patient selection.
Partelli S; Crippa S; Barugola G; Tamburrino D; Capelli P; D'Onofrio M; Pederzoli P; Falconi M
Ann Surg Oncol; 2011 Dec; 18(13):3608-14. PubMed ID: 21584836
[TBL] [Abstract][Full Text] [Related]
3. Radiographic Splenic Artery Involvement Is a Poor Prognostic Factor in Upfront Surgery for Patients with Resectable Pancreatic Body and Tail Cancer.
Kawai M; Hirono S; Okada KI; Miyazawa M; Kitahata Y; Kobayashi R; Ueno M; Hayami S; Yamaue H
Ann Surg Oncol; 2021 Mar; 28(3):1521-1532. PubMed ID: 32705517
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of splenic vessel infiltration in distal pancreatic adenocarcinoma: Comment on: Systematic review and meta-analysis of prognostic role of splenic vessels infiltration in resectable pancreatic cancer.
Joliat GR; Demartines N; Schäfer M
Eur J Surg Oncol; 2018 Jun; 44(6):859. PubMed ID: 29526368
[No Abstract] [Full Text] [Related]
5. Pathological and Radiological Splenic Vein Involvement are Predictors of Poor Prognosis and Early Liver Metastasis After Surgery in Patients with Pancreatic Adenocarcinoma of the Body and Tail.
Mizumoto T; Toyama H; Asari S; Terai S; Mukubo H; Yamashita H; Shirakawa S; Nanno Y; Ueda Y; Sofue K; Tanaka M; Kido M; Ajiki T; Fukumoto T
Ann Surg Oncol; 2018 Mar; 25(3):638-646. PubMed ID: 29264672
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of radiological splenic vessel involvement in patients with resectable pancreatic ductal adenocarcinoma of the body and tail: A retrospective analysis based on a large population.
Tan Q; Chen C; Wang Z; Zhang H; Liu X; Ke N
Eur J Radiol; 2023 Aug; 165():110952. PubMed ID: 37421772
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of splenic artery invasion for pancreatic cancer of the body and tail.
Fukami Y; Kaneoka Y; Maeda A; Takayama Y; Onoe S
Int J Surg; 2016 Nov; 35():64-68. PubMed ID: 27646614
[TBL] [Abstract][Full Text] [Related]
8. Radiological tumour invasion of splenic artery or vein in patients with pancreatic body or tail adenocarcinoma and effect on recurrence and survival.
Kang JS; Choi YJ; Byun Y; Han Y; Kim JH; Lee JM; Sohn HJ; Kim H; Kwon W; Jang JY
Br J Surg; 2021 Dec; 109(1):105-113. PubMed ID: 34718433
[TBL] [Abstract][Full Text] [Related]
9. Significance of radiographic splenic vessel involvement in the pancreatic ductal adenocarcinoma of the body and tail of the gland.
Hyun JJ; Rose JB; Alseidi AA; Biehl TR; Helton S; Coy DL; Kozarek RA; Rocha FG
J Surg Oncol; 2019 Aug; 120(2):262-269. PubMed ID: 31093997
[TBL] [Abstract][Full Text] [Related]
10. Spleen-preserving distal pancreatectomy with preservation of the splenic artery and vein for intraductal papillary-mucinous tumor (IPMT): three interesting cases.
Kimura W; Fuse A; Hirai I; Suto K; Suzuki A; Moriya T; Sakurai F
Hepatogastroenterology; 2003; 50(54):2242-5. PubMed ID: 14696508
[TBL] [Abstract][Full Text] [Related]
11. Prognostic Impact of Radiological Splenic Artery Involvement in Pancreatic Ductal Adenocarcinoma of the Body and Tail.
Kitamura K; Esaki M; Sone M; Sugawara S; Hiraoka N; Nara S; Ban D; Takamoto T; Mizui T; Shimada K
Ann Surg Oncol; 2022 Oct; 29(11):7047-7058. PubMed ID: 35691957
[TBL] [Abstract][Full Text] [Related]
12. The prognostic influence of intrapancreatic tumor location on survival after resection of pancreatic ductal adenocarcinoma.
Ruess DA; Makowiec F; Chikhladze S; Sick O; Riediger H; Hopt UT; Wittel UA
BMC Surg; 2015 Nov; 15():123. PubMed ID: 26615588
[TBL] [Abstract][Full Text] [Related]
13. Splenic vein tumor thrombosis is a major prognostic factor in distal pancreatic adenocarcinoma.
Jeune F; Collard M; Augustin J; Guedj N; Marchese U; Rouquette A; Cunha AS; Sebagh M; Pessaux P; Avérous G; Wagner M; Bachet JB; Vaillant JC; Sauvanet A; Gaujoux S
Surgery; 2024 Apr; 175(4):1111-1119. PubMed ID: 38071135
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis of benefits of portal-superior mesenteric vein resection in pancreatic resection for ductal adenocarcinoma.
Giovinazzo F; Turri G; Katz MH; Heaton N; Ahmed I
Br J Surg; 2016 Feb; 103(3):179-91. PubMed ID: 26663252
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis and Management of Borderline Resectable Pancreatic Adenocarcinoma.
Schwarz L; Katz MH
Hematol Oncol Clin North Am; 2015 Aug; 29(4):727-40. PubMed ID: 26226907
[TBL] [Abstract][Full Text] [Related]
16. Invasion of the splenic artery is a crucial prognostic factor in carcinoma of the body and tail of the pancreas.
Kanda M; Fujii T; Sahin TT; Kanzaki A; Nagai S; Yamada S; Sugimoto H; Nomoto S; Takeda S; Kodera Y; Morita S; Nakao A
Ann Surg; 2010 Mar; 251(3):483-7. PubMed ID: 20101172
[TBL] [Abstract][Full Text] [Related]
17. Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.
Glazer ES; Rashid OM; Pimiento JM; Hodul PJ; Malafa MP
Surgery; 2016 Nov; 160(5):1288-1293. PubMed ID: 27450715
[TBL] [Abstract][Full Text] [Related]
18. Arterial resection during pancreatectomy for pancreatic cancer: a systematic review and meta-analysis.
Mollberg N; Rahbari NN; Koch M; Hartwig W; Hoeger Y; Büchler MW; Weitz J
Ann Surg; 2011 Dec; 254(6):882-93. PubMed ID: 22064622
[TBL] [Abstract][Full Text] [Related]
19. Surgical strategy for patients with pancreatic body/tail carcinoma: who should undergo distal pancreatectomy with en-bloc celiac axis resection?
Okada K; Kawai M; Tani M; Hirono S; Miyazawa M; Shimizu A; Kitahata Y; Yamaue H
Surgery; 2013 Mar; 153(3):365-72. PubMed ID: 23046987
[TBL] [Abstract][Full Text] [Related]
20. The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma - A systematic review and meta-analysis.
Schorn S; Demir IE; Haller B; Scheufele F; Reyes CM; Tieftrunk E; Sargut M; Goess R; Friess H; Ceyhan GO
Surg Oncol; 2017 Mar; 26(1):105-115. PubMed ID: 28317579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
